Search Results - "MATSOUKAS, John"

Refine Results
  1. 1
  2. 2

    A methamphetamine vaccine using short monoamine and diamine peptide linkers and poly-mannose by Hossain, Md Kamal, Davidson, Majid, Feehan, Jack, Matsoukas, John M, Nurgali, Kulmira, Apostolopoulos, Vasso

    Published in Bioorganic & medicinal chemistry (01-11-2024)
    “…[Display omitted] •Methamphetamine (METH) substance use disorder growing public health concern, however current treatments are limited and ineffective.•There…”
    Get full text
    Journal Article
  3. 3

    Molecular Epidemiology of SARS-CoV-2: The Dominant Role of Arginine in Mutations and Infectivity by Ridgway, Harry, Ntallis, Charalampos, Chasapis, Christos T, Kelaidonis, Konstantinos, Matsoukas, Minos-Timotheos, Plotas, Panagiotis, Apostolopoulos, Vasso, Moore, Graham, Tsiodras, Sotirios, Paraskevis, Dimitrios, Mavromoustakos, Thomas, Matsoukas, John M

    Published in Viruses (22-01-2023)
    “…, , , , Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is a global challenge due to its ability to mutate into variants that spread more rapidly…”
    Get full text
    Journal Article
  4. 4
  5. 5

    Multiple Sclerosis: Immunopathology and Treatment Update by Dargahi, Narges, Katsara, Maria, Tselios, Theodore, Androutsou, Maria-Eleni, de Courten, Maximilian, Matsoukas, John, Apostolopoulos, Vasso

    Published in Brain sciences (07-07-2017)
    “…The treatment of multiple sclerosis (MS) has changed over the last 20 years. All immunotherapeutic drugs target relapsing remitting MS (RRMS) and it still…”
    Get full text
    Journal Article
  6. 6
  7. 7

    Role of Angiotensin II in Cardiovascular Diseases: Introducing Bisartans as a Novel Therapy for Coronavirus 2019 by Swiderski, Jordan, Gadanec, Laura Kate, Apostolopoulos, Vasso, Moore, Graham J, Kelaidonis, Konstantinos, Matsoukas, John M, Zulli, Anthony

    Published in Biomolecules (Basel, Switzerland) (02-05-2023)
    “…Cardiovascular diseases (CVDs) are the main contributors to global morbidity and mortality. Major pathogenic phenotypes of CVDs include the development of…”
    Get full text
    Journal Article
  8. 8

    Understanding the Driving Forces That Trigger Mutations in SARS-CoV-2: Mutational Energetics and the Role of Arginine Blockers in COVID-19 Therapy by Ridgway, Harry, Chasapis, Christos T, Kelaidonis, Konstantinos, Ligielli, Irene, Moore, Graham J, Gadanec, Laura Kate, Zulli, Anthony, Apostolopoulos, Vasso, Mavromoustakos, Thomas, Matsoukas, John M

    Published in Viruses (11-05-2022)
    “…SARS-CoV-2 is a global challenge due to its ability to mutate into variants that spread more rapidly than the wild-type virus. Because the molecular biology of…”
    Get full text
    Journal Article
  9. 9

    Diminazene aceturate uses different pathways to induce relaxation in healthy and atherogenic blood vessels by Kate Gadanec, Laura, Qaradakhi, Tawar, Renee McSweeney, Kristen, Matsoukas, John M., Apostolopoulos, Vasso, Burrell, Louise M, Zulli, Anthony

    Published in Biochemical pharmacology (01-02-2023)
    “…[Display omitted] Diminazene aceturate (DIZE), a putative angiotensin-converting enzyme 2 (ACE2) activator, elicits relaxation in various animal models. This…”
    Get full text
    Journal Article
  10. 10

    Streptococcus thermophilus ST285 Alters Pro-Inflammatory to Anti-Inflammatory Cytokine Secretion against Multiple Sclerosis Peptide in Mice by Dargahi, Narges, Matsoukas, John, Apostolopoulos, Vasso

    Published in Brain sciences (23-02-2020)
    “…Probiotic bacteria have beneficial effects to the development and maintenance of a healthy microflora that subsequently has health benefits to humans. Some of…”
    Get full text
    Journal Article
  11. 11

    From Angiotensin II to Cyclic Peptides and Angiotensin Receptor Blockers (ARBs): Perspectives of ARBs in COVID-19 Therapy by Matsoukas, John, Apostolopoulos, Vasso, Zulli, Anthony, Moore, Graham, Kelaidonis, Konstantinos, Moschovou, Kalliopi, Mavromoustakos, Thomas

    Published in Molecules (Basel, Switzerland) (25-01-2021)
    “…The octapeptide hormone angiotensin II is one of the most studied peptides with the aim of designing and synthesizing non-peptide mimetics for oral…”
    Get full text
    Journal Article
  12. 12
  13. 13

    Existence of Quantum Pharmacology in Sartans: Evidence in Isolated Rabbit Iliac Arteries by Gadanec, Laura Kate, Swiderski, Jordan, Apostolopoulos, Vasso, Kelaidonis, Kostantinos, Vidali, Veroniki P, Canko, Aleksander, Moore, Graham J, Matsoukas, John M, Zulli, Anthony

    “…Quantum pharmacology introduces theoretical models to describe the possibility of ultra-high dilutions to produce biological effects, which may help to explain…”
    Get full text
    Journal Article
  14. 14
  15. 15
  16. 16
  17. 17

    New Advances in Short Peptides: Looking Forward by Apostolopoulos, Vasso, Bojarska, Joanna, Chai, Tsun-Thai, Feehan, Jack, Kaczmarek, Krzysztof, Matsoukas, John M, Paredes Lopez, Octavio, Saviano, Michele, Skwarczynski, Mariusz, Smith-Carpenter, Jillian, Venanzi, Mariano, Wolf, Wojciech M, Zielenkiewicz, Piotr, Ziora, Zyta M

    Published in Molecules (Basel, Switzerland) (06-06-2022)
    “…It is beyond doubt that short peptides hold significant promise in bio-medicine, as the most versatile molecules, both structurally and functionally [...]…”
    Get full text
    Journal Article
  18. 18
  19. 19
  20. 20

    Receptor Interactions of Angiotensin II and Angiotensin Receptor Blockers—Relevance to COVID-19 by Moore, Graham J., Pires, Jose M., Kelaidonis, Konstantinos, Gadanec, Laura Kate, Zulli, Anthony, Apostolopoulos, Vasso, Matsoukas, John M.

    Published in Biomolecules (Basel, Switzerland) (03-07-2021)
    “…Angiotensin II (Ang II) may contain a charge relay system (CRS) involving Tyr/His/carboxylate, which creates a tyrosinate anion for receptor activation. Energy…”
    Get full text
    Journal Article